One of the largest veteran services organizations in the United States is making a push to change marijuana’s status as a Schedule I substance.
Tag Archives: Research
CHICAGO, Ill., May 23, 2017 /Weed Wire/ — Aclara Research, a leader in the development of patient and consumer insights within the medical cannabis industry, today released the results of The Illinois Medical Cannabis Patient Experience Study – the first of Illinois patients since the inception of the pilot program in 2012.
Researchers with Washington State University are looking for individuals to volunteer for a marijuana breathalyzer study. According to The Spokesman-Review, the study is attempting to determine if a marijuana breathalyzer can actually register “acute exposure” to THC.
The marijuana industry, and marijuana stock investors for that matter, have been expanding by leaps and bounds over the past two decades. One good way to keep this up is through university-based clinical studies. Studies like these really fan the flame of what might be possible with cannabis-based medicines.
FT. LAUDERDALE, Fla., May 15, 2017 /Weed Wire/ — DNA Brands Inc. (OTC PINK: DNAX) is pleased to announce today that it will be pursuing the CBD/MMJ/ Industrial Hemp marketplace after CEO Adrian McKenzie recently returned from Colorado
NANAIMO, British Columbia, May 15, 2017 /Weed Wire/ — Tilray, a global leader in medical cannabis research and production, today unveiled a new product categorization system that simplifies the process of choosing medical cannabis products for patients in Canada.
DENVER, May 12, 2017 /Weed Wire/ — As the 2017 General Assembly Session comes to a close, the Cannabis Business Alliance (CBA) applauds legislators for another productive session in regards to the continued regulation of the legal cannabis industry in Colorado.
According to a recent study published in the journal Natural Medicine, marijuana may help protect aging brains from cognitive decline.
Can this prolonged low-dose treatment with a compound in marijuana help reverse memory loss and improve cognitive skills? Researchers say it could.
DALLAS, Texas, May 8, 2017 /Weed Wire/ – Alternate Health Corp. (CSE: AHG and OTC: AHGIF), a diverse healthcare company that uses its expertise in technology and data analytics to revolutionize patient care and research in the emerging medical cannabis industry, today announced its results for the full year ending December 31, 2016.
FREDERICTON, New Brunswick, May 5, 2017 /Weed Wire/ — Premier Brian Gallant joined representatives from STU, Shoppers Drug Mart and the New Brunswick Health Research Foundation to announce the establishment of a health research chair on cannabis at the university.
Los Angeles’ Marijuana Don of Hollywood, BigMike Straumietis, shatters the stoner stereotype with his multi-million dollar cannabis company.
Here’s a pot stock that should prove immune to the adverse political winds emanating from the nation’s capital as marijuana is transitioning in the public eye.
Where medical marijuana is legal, adults are more likely to use the drug illegally and are at an increased risk of cannabis use disorder, according to a new study.
EVERGREEN, Colo., April 25, 2017 /Weed Wire/ — ebbu™, an industry leader in cannabis research, has developed the industry’s first line of fast-acting, 100% water-soluble, truly consistent edible products that deliver a predictable and reliable experience.
AUSTIN, Texas, April 20, 2017 /Weed Wire/ — More than 200 high-net worth investors from around the world, eager to invest in the fastest growing industry in America will gather at AT&T Conference & Education Center for a two day “Shark Tank”-like pitch forum.
If you’re looking for an educational 420 event in Southern California this year, the University of California, Los Angeles, has a light to shine on cannabis science.
\Sacramento County is moving forward with a proposal to ban all commercial marijuana activities. The first vote passed 3-1 on Tuesday afternoon.
On April 6, 2017, United States Rep. Matt Gaetz, R-Fla., announced the introduction of a bill to reschedule cannabis from Schedule I to Schedule III, shifting it from a class of drugs categorized as having no medical benefit to a class of drugs categorized as having known medical benefits paired with low rates of abuse and dependence.
LOS ANGELES, April 5, 2017 /Weed Wire/ — UCLA is hosting its first-ever cannabis research symposium April 20, from 8 a.m. to 4 p.m., at the Neuroscience Research Building Auditorium.
JERUSALEM, April 5, 2017 /Weed Wire/ — The Hebrew University of Jerusalem has announced the launch of a Multidisciplinary Center on Cannabinoid Research.
Argentina gave final legislative approval on Wednesday to a bill legalizing cannabis oil for medicinal use and permitting the federal government to grow marijuana for research and therapeutic purposes.
VANCOUVER, British Columbia, March 29, 2017 /Weed Wire/ — UBC scientists have scanned the genome of cannabis plants to find the genes responsible for giving various strains their lemony, skunky or earthy flavours, an important step for the budding legal cannabis industry.
WASHINGTON, March 28, 2017 /Weed Wire/ — Starting on Friday, April 7th and running until Tuesday, April 11th, medical cannabis industry business leaders, medical and legal professionals, advocates, and patients will gather at the Unity 2017 conference in Washington, D.C. to discuss common-sense policies and approaches to safe medical cannabis access and use. With the uncertainty of policies under a new U.S. administration, 2017 will be one of the most important years for medical cannabis policy ever.
Utah’s governor has signed off on a bill that allows research into the risks and benefits of medical marijuana.
Israel, a leader in marijuana research and health technology, is attracting international investment as it tries to position itself as a cutting-edge exporter in the rapidly-growing market for medical-grade cannabis.
Legal marijuana flat-Earthers, like U.S. Attorney General Jeff Sessions, have tried many methods to discredit breakthroughs in medical cannabis, but these efforts at discrediting cannabis stop at the U.S. border.
Marijuana grown by the federal government for research purposes does not have the same quality as the pot from other sources. Until recently, the U.S. federal government had to grow all the marijuana that would be used in scientific research, but researchers have found the government’s pot to be, essentially, irrelevant.
PHOENIX, March 17, 2017 /Weed Wire/ — As of March 15, 2017, five participants have received marijuana (cannabis) provided by the National Institute on Drug Abuse (NIDA) in an ongoing Phase 2 clinical trial sponsored by the non-profit Multidisciplinary Association for Psychedelic Studies (MAPS) at the Scottsdale Research Institute (SRI) in Phoenix, Ariz. MAPS is committed to sponsoring rigorous clinical research to develop cannabis into a prescription medicine through the Food and Drug Administration (FDA).
Oxford University, one of the oldest and most prestigious universities in the world, recently announced that it is launching a program to research the therapeutic benefits of cannabinoids in the treatment of cancer, inflammatory disease and pain.
OXFORD, England, March 15, 2017 /Weed Wire/ — Oxford University (“Oxford”) and Kingsley Capital Partners (“Kingsley”) today announce the launch of a pioneering research programme to investigate the role of cannabinoids in biology and medicine.
FORT LAUDERDALE, Fla., March 14, 2017 /Weed Wire/ — Greenspoon Marder is set to sponsor and speak at the CannaTech 2017 conference taking place in Tel Aviv on March 20-22nd.
SAN FRANCISCO, March 14, 2017 /Weed Wire/ — Enlucem, a strategic brand consultancy currently advising startups in the cannabis space, announced today the results of a detailed consumer study of Californians’ attitudes toward cannabis products.
Conducted by the Centers for Disease Control and Prevention, this is the first study to explore the association of the use of synthetic cannabinoids in U.S. high school students and health behaviors related to violence, mental health and sexual health.
Saturday afternoon, the New Mexico State House voted (41-26) to pass House Bill 155, co-sponsored by Rep. D. Armstrong (D-Albuquerque) and Rep. McCamley (D-Las Cruces) to establish a fund in the state treasury for research related to the production, uses, effects, and efficacy of medical marijuana.
An influential doctors group is beefing up warnings about marijuana’s potential harms for teens amid increasingly lax laws and attitudes on pot use.
According to a study recently published by the International Journal of Drug Policy, patients in Canada are substituting marijuana for opioids, benzodiazepines and antidepressants for symptom relief from pain and mental health conditions.
Sue Sisley, M.D., is leading the way in studying medical marijuana and post-traumatic stress disorder. In her talk, “Coping With PTSD,” hear Sisley discuss the first clinical trial to study the effects of medical marijuana in the treatment of post-traumatic stress disorder in military veterans.
In mid-February, researchers at Colorado State University and the Center for Health, Work & Environment at the Colorado School of Public Health, published “Work and Well-Being in the Colorado Cannabis Industry.”
CANBERRA, Australia, Feb. 20, 2017 /Weed Wire/ — On Friday 17 February 2017, the Office of Drug control issued the very first licence under the medicinal cannabis provisions of the Narcotic Drugs Act 1967. The licence is a cannabis research licence and has been issued to Cannoperations Pty Ltd, a wholly owned subsidiary of the Australian company Cann Group Limited.
WOBURN, Mass., Feb. 10, 2017 /Weed Wire/ — Medicinal Genomics and Courtagen Life Sciences, today announced an increasingly influential speaker lineup for CannMed 2017.
On Feb. 6, 2017, the first clinical trial to study the effects of medical marijuana in the treatment of post-traumatic stress disorder in military veterans dispensed medical marijuana to its first veteran at the Scottsdale Research Institute in Phoenix.
A Utah proposal that would allow universities to study medical marijuana has cleared its first committee meeting.
LOS ANGELES, Jan. 27, 2017 /Weed Wire/ — Despite major strides in legalization at the state level, illicit trade still accounts for nearly 90 percent of U.S. cannabis sales on average, according to a recent report on the state of the cannabis industry in North America.
Agriculture Ministry to finance 13 projects to lay basis of new generation of therapeutic marijuana products.
OAKLAND, Calif., Jan. 17, 2016 /Weed Wire/ — Arcview Market Research, the leading publisher of cannabis market research, released the first ever estimate of the entire North American cannabis market, including legal, medical and illicit marijuana sales.
A vote is expected in March or April to approve whether or not boxers should be able to smoke pot.
A comprehensive study slams many of the alleged benefits of marijuana and points to serious negative effects. What will the impact of this study be for marijuana stocks?
Research suggests cannabis legalization linked to rise in drinking rather than users swapping Budweiser for bud-smoking.
We recently took a trip around the Pacific Northwest to do some “research” into the legalization of marijuana in the United States and cannabis startups. What we saw was shocking to say the least. In a good way.